Stock Markets

Daily coverage of equity markets, sectors, and major indices.

In-depth reporting on U.S. and global stock markets, including index performance, sector rotation, earnings reactions, volatility trends, and notable single-stock moves. Designed to help traders and investors understand what is driving price action across equities.

Articles

9,649 total articles

CoStar shares climb after CEO purchases $2.48M in stock

CoStar shares climb after CEO purchases $2.48M in stock

CoStar Group shares rose 3% on Tuesday after a Form 4 filing disclosed that CEO Andrew Florance bought $2.48 million of company stock. The filing shows the purchase of 55,720 shares at $44.52 apiece, bringing Florance's total holdings to 1,586,866 shares. The trade arrives as the shares have fallen 33% year-to-date amid concerns about AI-driven dis…

Warsaw Stocks Slide; WIG30 Drops 4.35% to One-Month Low

Warsaw Stocks Slide; WIG30 Drops 4.35% to One-Month Low

Poland's benchmark WIG30 closed sharply lower, falling 4.35% to a fresh one-month low as losses concentrated in Basic Materials, Oil & Gas and Energy weighed on the market. While a handful of names gained, including Jastrzebska Spotka Weglowa SA and X Trade Brokers Dom Maklerski SA, large declines from KGHM and other energy and utility firms domina…

Cigna’s CEO David Cordani to Retire; Brian Evanko Tapped as Successor

Cigna’s CEO David Cordani to Retire; Brian Evanko Tapped as Successor

Cigna announced that CEO David Cordani will retire and become executive chair on July 1, with longtime insider Brian Evanko, 49, succeeding him as chief executive. The move comes as Cigna transitions some customers to a new rebate-free business model that the company says will compress margins over the next two years. The change surprised at least …

uniQure Shares Cut After FDA Signals Need for Sham-Controlled Phase 3 for Huntington’s Gene Therapy

uniQure Shares Cut After FDA Signals Need for Sham-Controlled Phase 3 for Huntington’s Gene Therapy

Analysts moved to lower uniQure N.V.'s ratings after the U.S. Food and Drug Administration indicated it would require a randomized, sham surgery-controlled Phase 3 trial for the company’s Huntington’s disease candidate, AMT-130. The FDA’s stance, communicated following a Type A meeting, reduces the likelihood of an accelerated approval pathway base…

Oslo OBX Drops 1.41% as Media, Transport and Financials Weigh on Market

Oslo OBX Drops 1.41% as Media, Transport and Financials Weigh on Market

Norway's Oslo OBX index finished the trading day down 1.41% as declines in the Media, Transport and Diversified Financials sectors outnumbered gains. Aker BP, Var Energi and Hafnia posted the session's largest advances and reached 52-week highs, while Subsea 7, Norwegian Air Shuttle and Storebrand led declines. Oil prices climbed sharply and key cu…

Two Drone Strikes Damage U.S. Embassy in Riyadh; Roof Partly Collapses

Two Drone Strikes Damage U.S. Embassy in Riyadh; Roof Partly Collapses

Two unmanned aerial vehicles struck the U.S. Embassy in Riyadh on Tuesday, striking the roof and perimeter of the chancery and causing a partial roof collapse, the State Department confirmed. The building remained smoke-contaminated after a second strike and staff were ordered to shelter in place. No injuries have been reported.

Turkey equities slip as BIST 100 posts 3.09% decline to one-month low

Turkey equities slip as BIST 100 posts 3.09% decline to one-month low

Turkey's main equity index closed lower on Tuesday, with the BIST 100 falling 3.09% to a new one-month low. Losses were concentrated in Basic Metals, Banking and Technology sectors. Market breadth was negative, and futures-linked commodity and FX moves added volatility to the session's close. Several large-cap names recorded notable gains and decli…